Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Source link
Neurocrine to Buy Soleno for $2.9 Billion
Date:
More like thisRelated
U.K. ambassador, in leaked remarks, said the “one country” with a “special relationship” with the U.S. is “probably Israel”
Britain's Ambassador to the U.S.,...
OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
OxyContin maker Purdue Pharma is set to be dissolved...
Free Answer Engine Optimization Tools to Benchmark LLM Visibility
I’ve spent considerable time testing free answer engine optimization...
Visa Revenue Climbs as Consumers Keep Spending
The payments company also bumped up its revenue and...